<DOC>
	<DOCNO>NCT01426737</DOCNO>
	<brief_summary>The purpose study explore long term glucose variability combination therapy metformin vildagliptin compare metformin - gliclazide combination . Multicenter , randomize , open , parallel group , Phase IV study , 18 month duration . - Trial medicinal product</brief_summary>
	<brief_title>The Swiss Glucose Variability Study</brief_title>
	<detailed_description />
	<mesh_term>Vildagliptin</mesh_term>
	<criteria>Inclusion criterion : 1 . Male female patient age =30 = 75 year . 2 . History type 2 diabetes least 6 month . 3 . Patients inadequately control ( i.e . reach target ) maximum tolerated dos metformin HbA1c 6.59.0 % . 4 . Patients inadequately control ( i.e . reach target ) maximum tolerated dos metformin body mass index ( BMI ) 2540 kg/m2 . 5 . Patients currently treat metformin , gliclazide glucose lower agent . 6 . Outpatient . 7 . If female childbearing potential : Will practice reliable birth control measure [ e.g. , surgical sterilization , hormonal contraception , doublebarrier method ( double combination IUD , male female condom spermicidal gel , diaphragm , sponge , cervical cap ) ] study treatment least 28 day completion study medication ; lactate pregnant ; document negative pregnancy test result baseline . Exclusion criterion : 1 . Type 1 diabetes define American Diabetes Association ( ADA ) . 2 . Type 2 diabetes currently ( last 3 month ) treat insulin glitazones . 3 . Acute chronic disease cause tissue hypoxia : cardiac respiratory insufficiency myocardial infarct within last 6 month 4 . Active liver disease alanine aminotransferase ( ALAT ) / aspartate aminotransferase ( ASAT ) &gt; 3 x upper limit normal . 5 . Relevant kidney disease : serum creatinine =133 µmol/l males &gt; 124 µmol/l female proteinuria &gt; 300 mg/l status post kidney transplantation severe infection intravascular administration contrast medium contain iod within last 7 day 6 . Severe neuropathy ( vibration perception base big toe &lt; 2/8 ) . 7 . Active proliferative diabetic retinopathy . 8 . Any clinically relevant major organ system disease include mental illness 9 . History malignancy 10 . Pancreatitis 11 . Porphyria 12 . Severe disturbance adrenal gland 13 . Severe disturbance thyroid gland 14 . Allergy vildagliptin one excipients 15 . Allergy metformin one excipients 16 . Allergy gliclazide , sulfonylurea sulfonamide one excipients . 17 . Drug alcohol abuse . 18 . Pregnant nursing ( lactate ) woman , pregnancy define state female conception termination gestation , confirm positive pregnancy test ( serum urine ) . 19 . Any condition could interfere participation study accord study protocol ability cooperate comply study procedure . 20 . Treatment investigational drug , within 30 day 5 halflives screen , whichever longer .</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>August 2011</verification_date>
</DOC>